Faculty profile

Anthony Whitton

Back to faculty

Professor EmeritusOncologyMcMaster University

Anthony Whitton

Professor Emeritus

Oncology

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2025

Email ORCID

Supervision signals

Emeritus professors are retired and rarely take new students.
No graduate courses on record.
13 publications in the last five years, latest in 2026.

These signals come from public records. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

104

Publications

2,949

Citations

h-index

Collaborators

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Other appointments

Pediatrics

Academic profiles

University Profile Search on Google Scholar iDORCID OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

whittona@HHSC.CA (905) 387-9711 ext. 64706

Research

Research areas, by share of publications

Glioma Diagnosis and TreatmentMedicine
Brain Metastases and TreatmentMedicine
Advanced Radiotherapy TechniquesPhysics and Astronomy
Meningioma and schwannoma managementMedicine
Childhood Cancer Survivors' Quality of LifeMedicine

Research areas are derived from OpenAlex topics of their publications.

104 publications.

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma

Kotecha R, Polley M-Y, Vogelbaum MA, Perry A, Ashby L, Modi JM, Alleman AM, Tsien CI, Barani IJ, Li J

Journal of Clinical Oncology2026

DOI: 10.1200/jco-25-01441

Stereotactic Body Radiation Therapy Boost Following Urgent 3D Conformal Radiation Therapy for Metastatic Epidural Spinal Cord Compression: A Phase 1 Feasibility Study

Donovan EK, Schnarr KL, Greenspoon JN, Wright JR, Okawara G, Hann C, Whitton A, Chow T, Wang Y, Parpia S

International Journal of Radiation Oncology Biology Physics2026

DOI: 10.1016/j.ijrobp.2025.12.020

Stereotactic Body Radiotherapy (SBRT) Boost Following Urgent 3D Conformal Radiotherapy in the Treatment of Metastatic Epidural Spinal Cord Compression (MESCC): A Phase I Feasibility Trial

Donovan E, Schnarr KL, Greenspoon JN, Wright J, Hann C, Whitton AC, Chow T, Wang Y, Parpia S, Whelan TJ

International Journal of Radiation Oncology Biology Physics2025

DOI: 10.1016/j.ijrobp.2025.06.2105

147 STEREOTACTIC BODY RADIOTHERAPY (SBRT) BOOST FOLLOWING URGENT 3D CONFORMAL RADIOTHERAPY FOR METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC): A PHASE 1 FEASIBILITY STUDY

Donovan E, Schnarr K, Greenspoon J, Wright J, Hann C, Whitton A, Chow T, Wang Y, Parpia S, Whelan T

Radiotherapy and Oncology2025

DOI: 10.1016/s0167-8140(25)04810-8

Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539

Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Barani IJ, Braunstein S, Bovi JA

Neuro-Oncology202351 citations

DOI: 10.1093/neuonc/noac137

Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.

Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y

Neuro-Oncology202318 citationsOpen Access

DOI: 10.1093/neuonc/noac262 PMID: W4310786023

Surgical Management of Meningiomas Involving the Torcula, Transverse Sinus, and Jugular Bulb: A Technical Note and Review of the Literature

Power RG, Lam FC, Whitton AC, Sharma S, Kasper EM

Journal of Neurological Surgery Reports20232 citationsOpen Access

DOI: 10.1055/s-0043-1772201 PMID: W4386157470

Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region.

Kisiel M, Reddy KKV, Provias J, Whitton AC, Lu J-Q

Clinical Neuropathology20232 citations

DOI: 10.5414/np301550

Corrigendum to: Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.

Neuro-Oncology2023

DOI: 10.1093/neuonc/noad062

QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402

Donovan L, Polly M-Y, Cairncross JG, Lassman A, Iwamoto F, Barani I, Souhami L, Pitot HC, Fisher B, Werner-Wasik M

Neuro-Oncology2023

DOI: 10.1093/neuonc/noad179.0970

Researchers with similar interests

Jeffrey Greenspoon

Oncology

Brain Metastases and Treatment, Glioma Diagnosis and Treatment

Katrin Conen

Medicine

Glioma Diagnosis and Treatment, Brain Metastases and Treatment

Douglas Wyman

Medical Imaging

Brain Metastases and Treatment, Advanced Radiotherapy Techniques

Adam Fleming

Pediatrics

Glioma Diagnosis and Treatment, Childhood Cancer Survivors' Quality of Life

Ronald Ramos

Medicine

Glioma Diagnosis and Treatment

Olufemi Ajani

Surgery

Glioma Diagnosis and Treatment

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Glioma Diagnosis and Treatment Dear Professor Whitton, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email

Something wrong or missing on this profile? Suggest a correction

Anthony Whitton

Research

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma

Stereotactic Body Radiation Therapy Boost Following Urgent 3D Conformal Radiation Therapy for Metastatic Epidural Spinal Cord Compression: A Phase 1 Feasibility Study

Stereotactic Body Radiotherapy (SBRT) Boost Following Urgent 3D Conformal Radiotherapy in the Treatment of Metastatic Epidural Spinal Cord Compression (MESCC): A Phase I Feasibility Trial

147 STEREOTACTIC BODY RADIOTHERAPY (SBRT) BOOST FOLLOWING URGENT 3D CONFORMAL RADIOTHERAPY FOR METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC): A PHASE 1 FEASIBILITY STUDY

Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539

Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.

Surgical Management of Meningiomas Involving the Torcula, Transverse Sinus, and Jugular Bulb: A Technical Note and Review of the Literature

Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region.

Corrigendum to: Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.

QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402

Frequent collaborators

Jeffrey Greenspoon

Ronald Duncan Barr

David Feeny

Crystal Hann

Sameer Parpia

Timothy Whelan

Researchers with similar interests

Jeffrey Greenspoon

Katrin Conen

Douglas Wyman

Adam Fleming

Ronald Ramos

Olufemi Ajani